Tirzepatide Beats Semaglutide With 21.6% Weight Loss
The SURMOUNT-5 trial found tirzepatide cut body weight by 21.6% on average versus 15.4% for semaglutide over 72 weeks in adults with obesity but no diabetes.
Tag
obesity-treatment
← Back
Tag
obesity-treatment
SURMOUNT-5 Trial: Tirzepatide vs Semaglutide in Obesity Management
The SURMOUNT-5 trial found tirzepatide cut body weight by 21.6% on average versus 15.4% for semaglutide over 72 weeks in adults with obesity but no diabetes.
1mo ago · 3 min · Big Stories
— End of feed —